In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene - PubMed (original) (raw)
In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene
N Elias et al. Arterioscler Thromb Vasc Biol. 2000 May.
Abstract
Familial hypobetalipoproteinemia (FHBL) is an autosomal codominant disorder that may result from different mutations in the apolipoprotein B (apoB) gene or chromosome 2. However, linkage of FHBL to the apoB gene was ruled out in 2 kindreds reported to date, and the genetic and metabolic bases for FHBL remain unknown. One of the reported kindreds is our 40-member F kindred, in which we found linkage of FHBL to a novel susceptibility region on chromosome 3p21. 1-2. In addition to having low apoB levels, some, but not all, of the affected subjects in the F kindred also had low levels of high density lipoprotein (HDL) cholesterol and apoA-I. Our aim was to define the metabolic bases of the disorder in the F kindred. Therefore, we studied the in vivo kinetics of apoB and apoA-I and very low density lipoprotein (VLDL) triglycerides in 4 affected subjects and 5 normolipidemic relatives. Deuterated leucine and deuterated glycerol were used to label the apolipoproteins and triglycerides, respectively. Compartmental modeling was used to obtain the kinetic parameters. Affected subjects had (1) normal fractional catabolic rates (FCRs) for VLDL apoB, (2) increased FCRs for low density lipoprotein (LDL) apoB (0.050+/-0.009 versus 0. 030+/-0.006 pools per hour for normal subjects, P=0.005), and (3) decreased production rates of VLDL apoB (11.4+/-1.7 versus 25.6+/-4. 9 mg. kg(-1). d(-1), P=0.003), LDL apoB (7.8+/-1.3 versus 12.7+/-3.7 mg. kg(-1). d(-1), P=0.04), and VLDL triglycerides (8.2+/-4.5 versus 19.6+/-10.8 58 micromol. kg(-1). h(-1), P=0.09). These data differ from those obtained in previously studied FHBL heterozygotes bearing apoB-2 and apoB-9, 2 very short truncations of apoB. Low HDL cholesterol and apoA-I levels were caused by higher apoA-I FCRs (0. 035+/-0.005 versus 0.018+/-0.005 pools per hour in controls, P<0.01) without significant decrease in apoA-I production rates (18.7+/-2.7 versus 22.8+/-5.6 mg. kg(-1). d(-1)). In conclusion, decreased secretion of apoB-containing lipoproteins and hypercatabolism of LDL account for low apoB and cholesterol levels in this novel form of FHBL.
Similar articles
- Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
Elias N, Patterson BW, Schonfeld G. Elias N, et al. Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2714-21. doi: 10.1161/01.atv.19.11.2714. Arterioscler Thromb Vasc Biol. 1999. PMID: 10559016 Clinical Trial. - Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR. Hooper AJ, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):E1484-90. doi: 10.1210/jc.2015-2731. Epub 2015 Aug 31. J Clin Endocrinol Metab. 2015. PMID: 26323024 - Familial hypobetalipoproteinemia: genetics and metabolism.
Schonfeld G, Lin X, Yue P. Schonfeld G, et al. Cell Mol Life Sci. 2005 Jun;62(12):1372-8. doi: 10.1007/s00018-005-4473-0. Cell Mol Life Sci. 2005. PMID: 15818469 Free PMC article. Review. - Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
Tarugi P, Averna M, Di Leo E, Cefalù AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S. Tarugi P, et al. Atherosclerosis. 2007 Dec;195(2):e19-27. doi: 10.1016/j.atherosclerosis.2007.05.003. Epub 2007 Jun 14. Atherosclerosis. 2007. PMID: 17570373 Review.
Cited by
- Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in ANGPTL3.
Blackburn NB, Meikle PJ, Peralta JM, Kumar S, Leandro AC, Bellinger MA, Giles C, Huynh K, Mahaney MC, Göring HHH, VandeBerg JL, Williams-Blangero S, Glahn DC, Duggirala R, Blangero J, Michael LF, Curran JE. Blackburn NB, et al. Circ Genom Precis Med. 2021 Jun;14(3):e003232. doi: 10.1161/CIRCGEN.120.003232. Epub 2021 Apr 22. Circ Genom Precis Med. 2021. PMID: 33887960 Free PMC article. Clinical Trial. - ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report.
Reeskamp LF, Millar JS, Wu L, Jansen H, van Harskamp D, Schierbeek H, Gipe DA, Rader DJ, Dallinga-Thie GM, Hovingh GK, Cuchel M. Reeskamp LF, et al. Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1753-1759. doi: 10.1161/ATVBAHA.120.315204. Epub 2021 Mar 11. Arterioscler Thromb Vasc Biol. 2021. PMID: 33691480 Free PMC article. - Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
Fazio S, Minnier J, Shapiro MD, Tsimikas S, Tarugi P, Averna MR, Arca M, Tavori H. Fazio S, et al. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3340-3348. doi: 10.1210/jc.2016-4043. J Clin Endocrinol Metab. 2017. PMID: 28633452 Free PMC article. - Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.
Minicocci I, Santini S, Cantisani V, Stitziel N, Kathiresan S, Arroyo JA, Martí G, Pisciotta L, Noto D, Cefalù AB, Maranghi M, Labbadia G, Pigna G, Pannozzo F, Ceci F, Ciociola E, Bertolini S, Calandra S, Tarugi P, Averna M, Arca M. Minicocci I, et al. J Lipid Res. 2013 Dec;54(12):3481-90. doi: 10.1194/jlr.P039875. Epub 2013 Sep 20. J Lipid Res. 2013. PMID: 24058201 Free PMC article. - Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.
Lam MC, Singham J, Hegele RA, Riazy M, Hiob MA, Francis G, Steinbrecher UP. Lam MC, et al. Case Rep Gastroenterol. 2012 May;6(2):429-37. doi: 10.1159/000339761. Epub 2012 Jul 3. Case Rep Gastroenterol. 2012. PMID: 22855658 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous